Company Number: 14338835

Analysis Date: 2025-07-20 11:03 UTC

Financial Health Assessment of APOQLAR UK LTD as of 31 December 2024

---

1. Financial Health Score: D

Explanation:
APOQLAR UK LTD shows clear symptoms of financial distress, primarily due to significant negative net current assets and net liabilities. The company’s current liabilities far exceed its current assets, indicating liquidity problems. Although it is a young company (incorporated in 2022) and in a growth-oriented sector (software development), the financial "vital signs" suggest the business is struggling to maintain a healthy financial state.

---

2. Key Vital Signs

Metric	2024 Value (£)	Interpretation
Current Assets	11,422	Low level of liquid and short-term assets
Cash at Bank	1,905	Very limited cash reserves, weak cash flow
Debtors (Amounts owed to company)	9,517	Some receivables, but collection may be slow
Current Liabilities	200,872	Very high short-term debts due within 1 year
Net Current Assets (Working Capital)	-189,450	Negative working capital, a critical warning
Net Assets (Total Equity)	-189,450	Negative equity indicates accumulated losses
Shareholders’ Funds	-190,450	Shareholders' funds are deeply negative
Intercompany Loan (Other Creditors)	191,188	Large loan from parent company, related party debt

Interpretation of Vital Signs (Analogy):
The company’s financial "pulse" is weak. The very negative working capital is like a patient with a dangerously low blood volume—there simply isn't enough "liquid" resource to cover immediate obligations. Negative net assets (akin to a negative net worth) indicate accumulated losses that have eroded shareholder equity, a serious "symptom" of financial strain.

---

3. Diagnosis

APOQLAR UK LTD is currently in a financially precarious position:

• Liquidity Crisis: The company has significantly more short-term liabilities than current assets, indicating it may struggle to meet immediate obligations. This is a classic symptom of cash flow distress.

• Negative Net Worth: The negative net assets and shareholders’ funds reveal that the business has been operating at a loss, eroding equity and potentially requiring capital injections to stay afloat.

• Dependence on Parent Company: A large intercompany loan (£191,188) from Apoqlar GmbH is the major component of current liabilities. This suggests the parent company is providing critical funding support. While this may provide a lifeline, it also means the company is reliant on external (related party) financing rather than generating its own liquidity.

• Growth Stage Considerations: Founded in 2022 and operating in software development, the company may be in an early investment phase, which can explain losses and negative equity. However, the degree of working capital deficiency is a red flag that requires management attention.

• Limited Cash Reserves: Cash on hand is very low (£1,905), further exacerbating liquidity risk.

In medical terms, the company is showing "symptoms of distress" that could lead to financial "collapse" without intervention, though the parent company loan currently acts like an "intravenous drip" keeping it alive.

---

4. Recommendations

To improve financial wellness and stabilize the company, the following actions are advised:

1. Improve Cash Flow Management:

   • Accelerate debtor collections to convert receivables into cash faster.
   • Negotiate longer payment terms with creditors to ease cash outflows.
   • Monitor daily cash position closely to avoid liquidity crunches.

2. Restructure Debt:

   • Engage with the parent company to formalize or restructure the intercompany loan possibly into longer-term financing or equity conversion to improve working capital ratios.
   • Explore external funding or capital injection to strengthen equity base.

3. Cost Control and Operational Efficiency:

   • Review operating expenses and limit discretionary spending.
   • Focus on achieving operational milestones that can generate revenue and reduce losses.

4. Financial Planning and Forecasting:

   • Develop detailed cash flow forecasts to anticipate liquidity needs.
   • Implement tighter budgeting controls to ensure spending aligns with available resources.

5. Consider Strategic Business Review:

   • Assess business model viability and growth plans to ensure sustainable path to profitability.
   • Consider potential for partnerships, new revenue streams, or cost synergies.

---